Winfred C. Wang

St. Jude Children's Research Hospital — United States

Medicine · Health Sciences

65h-index15.1kcitations305works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(233), Iron Metabolism and Disorders(146), Blood groups and transfusion(67), Prenatal Screening and Diagnostics(45), Bone and Joint Diseases(20)

Publications305 total

Development of the sickle cell outcome grading system (SCOGS), a novel classification system for sickle cell disease severity
Blood·2025
Cerebral blood flow trajectories in paediatric sickle cell anaemia by age, region, and treatment associations
British Journal of Haematology·2025Open Access
Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial
Blood Advances·2025· 3 citedOpen Access
Outcomes of Immunosuppressive Therapy in Children Less Than Three Years of Age with Idiopathic Severe Aplastic Anemia: A North American Collaboration
Blood·2024· 1 citedOpen Access
Hydroxyurea maintains working memory function in pediatric sickle cell disease
PLoS ONE·2024· 6 citedOpen Access
Enuresis and Hyperfiltration in Children with Sickle Cell Disease
2024Open Access
Hydroxyurea maintains working memory function in pediatric sickle cell disease
2023· 1 citedOpen Access
Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease
Current Research in Translational Medicine·2023· 2 citedOpen Access
SLEEP DISRUPTION DUE TO HOSPITAL NOISES
2023· 2 citedOpen Access
Intensive hydroxyurea dosing in very young children with sickle cell anemia
Blood Advances·2023· 3 citedOpen Access
Sickle cell disease and social determinants of health: A scoping review
Pediatric Blood & Cancer·2022· 57 citedOpen Access
Eltrombopag in Pediatric Patients with Previously Untreated or Refractory/Relapsed Severe Aplastic Anemia: The Phase II Escalate Trial
Blood·2022· 3 cited
Hydroxyurea Dosing in Very Young Children with Sickle Cell Anemia: A Multicenter, Randomized, Controlled Trial (HUGKISS)
Blood·2022· 1 cited
Optimizing the Frequency of Transcranial Doppler (TCD) Exams in Children with Sickle Cell Anemia
Blood·2022
Hydroxyurea Dosing in Very Young Children (HUGKISS): Challenges of Study Design
Blood·2022
Assessment of transition readiness to predict health care utilization during transition to adult care in sickle cell disease
Expert Review of Hematology·2022· 3 citedOpen Access
Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controls
British Journal of Haematology·2022· 4 citedOpen Access
Neurocognitive functioning in children with sickle cell anemia and history of abnormal transcranial doppler ultrasonography
Pediatric Blood & Cancer·2022· 2 citedOpen Access
Sickle Cell Disease and Social Determinants of Health -- A Scoping Review
2022· 2 citedOpen Access
Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia✰,✰✰
Current Research in Translational Medicine·2022· 12 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Russell E. Ware(13), Scott T. Miller(13), Elliott Vichinsky(12), Charles H. Pegelow(11), Zora R. Rogers(9), Rathi V. Iyer(8), Thomas R. Kinney(7), James F. Casella(6), Bruce Thompson(6), Kim Smith‐Whitley(6), Kwaku Ohene‐Frempong(6), Gerald M. Woods(6), Sharada A. Sarnaik(5), Lynn Wynn(5), Abdullah Kutlar(5), Robert J. Adams(5), Dianne Gallagher(5), Zhaoyu Luo(5), Doris L. Wethers(4), Samir K. Ballas(4)